Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001553188 | SCV001774009 | likely benign | not provided | 2020-06-15 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268516 | SCV002550859 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002568345 | SCV003018376 | likely benign | Tietz syndrome; Waardenburg syndrome type 2A; Melanoma, cutaneous malignant, susceptibility to, 8 | 2024-12-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004945692 | SCV005444988 | likely benign | Hereditary cancer-predisposing syndrome | 2024-10-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004746422 | SCV005352933 | likely benign | MITF-related disorder | 2024-04-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |